JAGX News
Archived Headlines
- Dog diarrhea deal drops out: Jaguar Animal Health postpones IPO 11/05/14
- Week Ahead: 12 US IPOs planned for the week of November 3 as the IPO market reignites 11/02/14
- Year's number 2 IPO: Dog diarrhea biotech Jaguar Animal Health sets terms for $40 million IPO 10/28/14
- Watery diarrhea biotech Jaguar Animal Health files for a $70 million IPO 08/27/14
US IPO Weekly Recap: With 6 IPOs, the year's largest company goes public
Six companies went public in the past week, raising $1.4 billion. Half traded up 10% or more, and half had negative or no return. For the second week in a row, the general partner of a midstream natural gas pipelines MLP priced an upsized IPO above its...read more
Pet diarrhea biotech Jaguar Animal Health prices downsized IPO at $7, the low end of its original range
Jaguar Animal Health, which is developing an animal formulation of its parent's approved diarrhea treatment, raised $20 million by offering 2.86 million shares at $7, the low end of its originally proposed $7 to $9 range. Jaguar Animal Health listed on the...read more
Week ahead: 9 IPOs planned for the week of May 11
Nine IPOs are scheduled to raise $1.4 billion this week. The IPO market could see the year's largest company and the year's largest biotech by market cap begin trading in the US....read more
Doggy diarrhea biotech tries IPO attempt No. 2: Jaguar Animal Health set for $22 million IPO
Jaguar Animal Health, which is developing an animal formulation of its parent's approved diarrhea treatment, announced terms for its IPO on Friday. The San Francisco, CA-based company plans to raise $22 million by offering 3.2 million shares at a price of...read more